ACS Publications. Most Trusted. Most Cited. Most Read
Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors
My Activity

Figure 1Loading Img
    Letter

    Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors
    Click to copy article linkArticle link copied!

    • Szymon Pach
      Szymon Pach
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
      More by Szymon Pach
    • Tim M. Sarter
      Tim M. Sarter
      Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia
    • Rafe Yousef
      Rafe Yousef
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
      More by Rafe Yousef
    • David Schaller
      David Schaller
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
    • Silke Bergemann
      Silke Bergemann
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
    • Christoph Arkona
      Christoph Arkona
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
    • Jörg Rademann
      Jörg Rademann
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
    • Christoph Nitsche
      Christoph Nitsche
      Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia
    • Gerhard Wolber*
      Gerhard Wolber
      Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany
      *Email: [email protected]
    Other Access OptionsSupporting Information (1)

    ACS Medicinal Chemistry Letters

    Cite this: ACS Med. Chem. Lett. 2020, 11, 4, 514–520
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsmedchemlett.9b00629
    Published March 3, 2020
    Copyright © 2020 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    The pivotal role of viral proteases in virus replication has already been successfully exploited in several antiviral drug design campaigns. However, no efficient antivirals are currently available against flaviviral infections. In this study, we present lead-like small molecule inhibitors of the Zika Virus (ZIKV) NS2B-NS3 protease. Since only few nonpeptide competitive ligands are known, we take advantage of the high structural similarity with the West Nile Virus (WNV) NS2B-NS3 protease. A comparative modeling approach involving our in-house software PyRod was employed to systematically analyze the binding sites and develop molecular dynamics-based 3D pharmacophores for virtual screening. The identified compounds were biochemically characterized revealing low micromolar affinity for both ZIKV and WNV proteases. Their lead-like properties together with rationalized binding modes represent valuable starting points for future lead optimization. Since the NS2B-NS3 protease is highly conserved among flaviviruses, these compounds may also drive the development of pan-flaviviral antiviral drugs.

    Copyright © 2020 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00629.

    • Computational and experimental methods, and supplementary tables and figures (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 10 publications.

    1. Barbara Schroeder, Peter Demirel, Christina Fischer, Enaam Masri, Stephanie Kallis, Lisa Redl, Thomas Rudolf, Silke Bergemann, Christoph Arkona, Christoph Nitsche, Ralf Bartenschlager, Jörg Rademann. Nanoparticular Inhibitors of Flavivirus Proteases from Zika, West Nile and Dengue Virus Are Cell-Permeable Antivirals. ACS Medicinal Chemistry Letters 2021, 12 (12) , 1955-1961. https://doi.org/10.1021/acsmedchemlett.1c00515
    2. Niklas J. Braun, Simon Huber, Luna C. Schmacke, Andreas Heine, Torsten Steinmetzer. Boroleucine‐Derived Covalent Inhibitors of the ZIKV Protease. ChemMedChem 2023, 18 (3) https://doi.org/10.1002/cmdc.202200336
    3. Igor José dos Santos Nascimento, Érica Erlanny da Silva Rodrigues, Manuele Figueiredo da Silva, João Xavier de Araújo-Júnior, Ricardo Olimpio de Moura. Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses. Current Topics in Medicinal Chemistry 2022, 22 (29) , 2435-2462. https://doi.org/10.2174/1568026623666221122121330
    4. Shobana Sundar, Shanmughavel Piramanayagam, Jeyakumar Natarajan. A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika. Virus Genes 2022, 58 (3) , 151-171. https://doi.org/10.1007/s11262-022-01898-5
    5. Matej Janežič, Katja Valjavec, Kaja Bergant Loboda, Barbara Herlah, Iza Ogris, Mirijam Kozorog, Marjetka Podobnik, Simona Golič Grdadolnik, Gerhard Wolber, Andrej Perdih. Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα. International Journal of Molecular Sciences 2021, 22 (24) , 13474. https://doi.org/10.3390/ijms222413474
    6. Crystall Swarbrick, Vasiliki Zogali, Kitti Wing Ki Chan, Dimitrios Kiousis, Chin Piaw Gwee, Sai Wang, Julien Lescar, Dahai Luo, Mark von Itzstein, Minos-Timotheos Matsoukas, George Panagiotakopoulos, Subhash G. Vasudevan, Gerasimos Rassias. Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus protease. European Journal of Medicinal Chemistry 2021, 224 , 113695. https://doi.org/10.1016/j.ejmech.2021.113695
    7. Saan Voss, Christoph Nitsche. Targeting the protease of West Nile virus. RSC Medicinal Chemistry 2021, 12 (8) , 1262-1272. https://doi.org/10.1039/D1MD00080B
    8. Hye Jin Shin, Mi-Hwa Kim, Joo-Youn Lee, Insu Hwang, Gun Young Yoon, Hae Soo Kim, Young-Chan Kwon, Dae-Gyun Ahn, Kyun-Do Kim, Bum-Tae Kim, Seong-Jun Kim, Chonsaeng Kim. Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses. Microorganisms 2021, 9 (3) , 545. https://doi.org/10.3390/microorganisms9030545
    9. David Schaller, Szymon Pach, Marcel Bermudez, Gerhard Wolber. Exploiting Water Dynamics for Pharmacophore Screening. 2021, 227-238. https://doi.org/10.1007/978-1-0716-1209-5_13
    10. Niklas J. Braun, Jun P. Quek, Simon Huber, Jenny Kouretova, Dorothee Rogge, Heike Lang‐Henkel, Ezekiel Z. K. Cheong, Bing L. A. Chew, Andreas Heine, Dahai Luo, Torsten Steinmetzer. Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses. ChemMedChem 2020, 15 (15) , 1439-1452. https://doi.org/10.1002/cmdc.202000237

    ACS Medicinal Chemistry Letters

    Cite this: ACS Med. Chem. Lett. 2020, 11, 4, 514–520
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsmedchemlett.9b00629
    Published March 3, 2020
    Copyright © 2020 American Chemical Society

    Article Views

    1150

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.